Business Description
Syros Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US87184Q1076
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.76 | |||||
Equity-to-Asset | 0.11 | |||||
Debt-to-Equity | 4.1 | |||||
Debt-to-EBITDA | -0.45 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -9.56 | |||||
Beneish M-Score | -4.84 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -52.5 | |||||
3-Year EBITDA Growth Rate | 31.4 | |||||
3-Year EPS without NRI Growth Rate | 37.6 | |||||
3-Year FCF Growth Rate | 33.5 | |||||
3-Year Book Growth Rate | -66.1 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 37.59 | |||||
9-Day RSI | 41.69 | |||||
14-Day RSI | 43.89 | |||||
6-1 Month Momentum % | 91.44 | |||||
12-1 Month Momentum % | 45.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.01 | |||||
Quick Ratio | 3.01 | |||||
Cash Ratio | 2.9 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -67.6 | |||||
Shareholder Yield % | 1.16 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -1779.23 | |||||
Net Margin % | -2069.8 | |||||
FCF Margin % | -1481.03 | |||||
ROE % | -291.3 | |||||
ROA % | -86.32 | |||||
ROIC % | -318.54 | |||||
ROC (Joel Greenblatt) % | -660.68 | |||||
ROCE % | -102 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 20.44 | |||||
PB Ratio | 9.01 | |||||
Price-to-Tangible-Book | 9.12 | |||||
EV-to-EBIT | -0.63 | |||||
EV-to-Forward-EBIT | -0.14 | |||||
EV-to-EBITDA | -0.64 | |||||
EV-to-Revenue | 12.52 | |||||
EV-to-Forward-Revenue | 27.93 | |||||
EV-to-FCF | -0.86 | |||||
Earnings Yield (Greenblatt) % | -158.86 | |||||
FCF Yield % | -77.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Syros Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 6.494 | ||
EPS (TTM) (€) | -4.668 | ||
Beta | 2.15 | ||
Volatility % | 161.74 | ||
14-Day RSI | 43.89 | ||
14-Day ATR (€) | 0.126022 | ||
20-Day SMA (€) | 4.7145 | ||
12-1 Month Momentum % | 45.13 | ||
52-Week Range (€) | 1.97 - 7.44 | ||
Shares Outstanding (Mil) | 26.73 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Syros Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Syros Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Syros Pharmaceuticals Inc Frequently Asked Questions
What is Syros Pharmaceuticals Inc(FRA:0S90)'s stock price today?
When is next earnings date of Syros Pharmaceuticals Inc(FRA:0S90)?
Does Syros Pharmaceuticals Inc(FRA:0S90) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |